Are there documented cases of liver damage from DMAA-containing supplements?

Checked on January 24, 2026
Disclaimer: Factually can make mistakes. Please verify important information or breaking news. Learn more.

Executive summary

Documented cases linking supplements that contained DMAA (1,3‑dimethylamylamine) to acute liver injury exist in the medical and public-health record: case series among U.S. service members, a large cluster of hepatitis cases tied to OxyELITE Pro in Hawaii with hospitalizations, transplants and at least one death, and multiple poison‑center and regulatory reports describing liver failure temporally associated with DMAA‑containing products [1] [2] [3] [4]. At the same time, investigators and manufacturers have disputed direct causation in some outbreaks, noting confounders such as other ingredients, possible counterfeit products, and limits of epidemiologic proof [2] [5] [6].

1. Documented clinical reports: military case series and individual liver‑failure events

Peer‑reviewed case reports include a seven‑case series from a Southern California military treatment facility in which service members who used OxyELITE Pro (a product that had included DMAA) developed acute liver injury, with two requiring liver transplants, and other military reports describing deaths and organ failure after DMAA‑containing supplements [1] [7] [8].

2. Outbreaks and clusters: Hawaii investigation and large numbers hospitalized

State and federal health agencies investigated a cluster of non‑viral hepatitis in Hawaii linked epidemiologically to OxyELITE Pro that resulted in dozens of illnesses, hospitalizations, two liver transplants and at least one death; the FDA and news organizations reported the association and launched probes into the product supply [2] [3] [5].

3. Surveillance and poison‑center data that reinforce reports of liver injury

Analyses of poison‑center calls and surveillance data documented exposures to DMAA‑containing products and described serious outcomes including reports of liver and kidney failure among consumers, strengthening the temporal association between DMAA product use and severe adverse events [4] [9].

4. Mechanistic and toxicology context — plausible but not settled

Laboratory and pharmacology work shows DMAA is a stimulant and vasoconstrictor with cardiovascular risks, and some in vitro studies suggest interactions with liver enzymes that could alter drug metabolism; these findings support biological plausibility for harm but do not by themselves prove DMAA was the hepatotoxin in every reported case [10] [11] [12].

5. Alternative explanations, counterclaims, and limits of causality

Several investigators and reviews caution that causation is difficult to establish: OxyELITE Pro formulations varied over time, some implicated batches lacked DMAA, other ingredients (for example aegeline or green‑tea extracts) have been proposed as culprits, counterfeit or reformulated products may account for clustering, and epidemiologic analyses have noted potential reporting biases—facts stressed in academic critiques and industry statements [6] [2] [5].

6. Regulatory and public‑health response consistent with concern

Regulators treated DMAA as a safety threat: the FDA issued warnings, enforcement actions and pushed DMAA products off the U.S. market after accumulating adverse‑event reports and investigations, a stance reflected in FDA communications and public health advisories [3] [12].

Conclusion — balanced answer to the question

Yes: there are documented clinical cases, case series and public‑health investigations that link consumption of DMAA‑containing dietary supplements to acute liver injury, liver failure, transplants and at least one death [1] [2] [3]. However, definitive proof that DMAA itself—versus other ingredients, contaminants, counterfeit products or product formulation changes—was the causal agent in every reported case is not uniformly established in the literature, and peer reviewers and authors have flagged those uncertainties [6] [2]. The accumulated clinical reports, regulatory actions, and surveillance data together created sufficient concern for regulators to remove DMAA from dietary supplements and to treat the association as a serious safety signal [3] [12].

Want to dive deeper?
What ingredients besides DMAA have been implicated in OxyELITE Pro–associated liver injuries?
How did the FDA and state health authorities investigate and trace the Hawaii OxyELITE Pro hepatitis cluster in 2013?
What is the evidence on DMAA’s pharmacology and its potential to cause hepatotoxicity in humans?